AT360654B - Verfahren zur herstellung von pharmazeutischen zusammensetzungen - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen

Info

Publication number
AT360654B
AT360654B AT430677A AT430677A AT360654B AT 360654 B AT360654 B AT 360654B AT 430677 A AT430677 A AT 430677A AT 430677 A AT430677 A AT 430677A AT 360654 B AT360654 B AT 360654B
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
producing pharmaceutical
producing
compositions
pharmaceutical
Prior art date
Application number
AT430677A
Other languages
English (en)
Other versions
ATA430677A (de
Inventor
Takuzo Kamishita
Original Assignee
Toko Yakuhin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toko Yakuhin Kogyo Kk filed Critical Toko Yakuhin Kogyo Kk
Publication of ATA430677A publication Critical patent/ATA430677A/de
Application granted granted Critical
Publication of AT360654B publication Critical patent/AT360654B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT430677A 1976-06-21 1977-06-17 Verfahren zur herstellung von pharmazeutischen zusammensetzungen AT360654B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7296076A JPS52156913A (en) 1976-06-21 1976-06-21 Production of injectionable medicine

Publications (2)

Publication Number Publication Date
ATA430677A ATA430677A (de) 1980-06-15
AT360654B true AT360654B (de) 1981-01-26

Family

ID=13504445

Family Applications (1)

Application Number Title Priority Date Filing Date
AT430677A AT360654B (de) 1976-06-21 1977-06-17 Verfahren zur herstellung von pharmazeutischen zusammensetzungen

Country Status (11)

Country Link
US (1) US4472376A (de)
JP (1) JPS52156913A (de)
AT (1) AT360654B (de)
BE (1) BE855780A (de)
CH (1) CH638402A5 (de)
DE (1) DE2727913A1 (de)
DK (1) DK271677A (de)
ES (1) ES459938A1 (de)
FR (1) FR2355510A1 (de)
GB (1) GB1552521A (de)
NL (1) NL189548C (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135617A1 (de) * 1983-08-29 1985-04-03 Mepha AG Indomethacin enthaltende, gelartige Salbe

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6042766B2 (ja) 1978-12-09 1985-09-25 日本化薬株式会社 基剤
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
JPS5913714A (ja) * 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
SE457055B (sv) * 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US4863792A (en) * 1988-10-14 1989-09-05 Minnesota Mining And Manufacturing Company Multi-layer laminates of microporous films
JPH0347134A (ja) * 1989-03-08 1991-02-28 Hoechst Japan Ltd ヒドロゲル製剤およびキセロゲル製剤の製造法
US5256737A (en) * 1990-03-05 1993-10-26 Sigma Prodotti Chimici S.P.A. Thickening agents, processes for the preparation thereof and use thereof
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
FR2668705A1 (fr) * 1990-11-06 1992-05-07 Bouchara Sa Nouvelles preparations dermiques a action phlebotonique et leur procede de preparation.
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
FR2726469B1 (fr) * 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides
GB9422571D0 (en) * 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
FR2739559B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Gel pour hormonotherapie locale de la secheresse vaginale
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20050180985A9 (en) * 2001-10-04 2005-08-18 Vladoianu Ion R. Live attenuated salmonella strains for producing monovalent or multivalent vaccines
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7371399B2 (en) * 2004-07-23 2008-05-13 Prescott Albert G Polymer gel containing hyaluronic acid and collagen, and its use in joints
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
DE102004062468A1 (de) * 2004-12-20 2006-06-29 Manuela Glaschak Zusammensetzung zur vaginalen Anwendung
US8637096B2 (en) 2009-12-04 2014-01-28 Curtis C. Stojan Compositions and method for enhancing insulin activity
US20110135681A1 (en) * 2009-12-04 2011-06-09 Stojan Curtis C Composition and Method for Enhancing Insulin Activity
GB201010954D0 (en) 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
ES2395801B1 (es) * 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL57113C (de) * 1941-05-04
DE751427C (de) * 1942-11-15 1953-01-19 Ig Farbenindustrie Ag Grundlage fuer Zitzenstifte
US2823163A (en) * 1956-10-11 1958-02-11 Richard K Thoms Antivaginitis process and cation exchange resin composition
GB1023895A (en) * 1964-06-03 1966-03-30 Plough Alcoholic compositions
CH476499A (de) * 1964-12-31 1969-08-15 Ciba Geigy Mischung zum Überziehen von Rektal-Kapseln
IT1050353B (it) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved Supporti per sostanze biologigamente attive
DK135267A (de) * 1971-02-25
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
LU70487A1 (de) * 1974-07-08 1976-05-31
DE3106620A1 (de) * 1981-02-23 1982-09-02 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitung in form eines mikroklysmas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135617A1 (de) * 1983-08-29 1985-04-03 Mepha AG Indomethacin enthaltende, gelartige Salbe

Also Published As

Publication number Publication date
BE855780A (nl) 1977-12-19
DE2727913A1 (de) 1977-12-29
JPS5538926B2 (de) 1980-10-07
ES459938A1 (es) 1979-06-01
FR2355510B1 (de) 1981-12-11
FR2355510A1 (fr) 1978-01-20
DE2727913C2 (de) 1987-12-03
ATA430677A (de) 1980-06-15
NL189548C (nl) 1993-05-17
CH638402A5 (de) 1983-09-30
NL7706301A (nl) 1977-12-23
JPS52156913A (en) 1977-12-27
DK271677A (da) 1977-12-22
US4472376A (en) 1984-09-18
GB1552521A (en) 1979-09-12
NL189548B (nl) 1992-12-16

Similar Documents

Publication Publication Date Title
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
LU77562A1 (de) Verfahren zur herstellung von neuen pharmazeutischen praeparaten
AT373146B (de) Verfahren zur herstellung von tabletten
AT363196B (de) Verfahren zur herstellung von androstan-17-on-derivaten
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
AT366576B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT343276B (de) Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung
AT359197B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT358729B (de) Verfahren zur herstellung von 3-halogenmethyl-3 -cephemen
AT352138B (de) Verfahren zur herstellung von 2-chlorsulfinyl- azetidin-4-onen
AT348499B (de) Verfahren zur herstellung von aethylchlorthioformiat
AT347439B (de) Verfahren zur herstellung von benzoylcyanid
AT363174B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen
AT364817B (de) Verfahren zur herstellung von aminocyclolen
AT347438B (de) Verfahren zur herstellung von benzoylcyanid
AT350582B (de) Verfahren zur herstellung von n-mehtyl-harn- stoffen
AT355013B (de) Verfahren zur herstellung von 2-oxo-pyrrolidin- n-alkylamiden
AT343125B (de) Verfahren zur herstellung von 3-phenylpyridazon- (6)
AT376633B (de) Verfahren zur herstellung von phosphornitriden
PT64875A (de) Verfahren zur herstellung von n-alenyl-2-aminomethyl-pyrrolidinen
ATA966976A (de) Verfahren zur herstellung von 2-aminoindanderivaten
ATA136279A (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT361620B (de) Verfahren zur herstellung von 6-alpha -methoxypenicillinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee